Yi Xia, MD

Attending Physician, Department of Hematology
Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, China (People's Republic)

N/A

Poster(s):

• 1008 - Clinical characteristics and outcome of chronic lymphocytic leukemia patients with renal involvement in the era of target drugs

• 1113 - Stereotyped BCR Subset #8 in Chinese CLL: Molecular Genetics, Clinical Behaviour, and Prognosis

• 1120 - Serum LC-MS based untargeted metabolomics machine learning for distinguishing asymptomatic and symptomatic CLL/SLL and predicting TTFT

• 1204 - EGR2 Hotspot Mutations Drive BTKi Resistance in Chronic Lymphocytic Leukemia via CD27-CD70 Interaction-Mediated T-Cell Exhaustion

• 1429 - Orelabrutinib, fludarabine, cyclophosphamide and obinutuzumab (OFCG) for first-line treatment of chronic lymphocytic leukemia: a multicenter, investigator-initiated phase II trial (cwcll-001 trial)

• 1431 - The role of Minimal Residual Disease in chronic lymphocytic leukemia

• 1603 - Single-cell transcriptome analysis reveals molecular mechanism of stem-like cells in Richter Transformation

• 1702 - Immune Cytopenia with Chronic Lymphocytic Leukemia: A Real-World Clinical Characteristic Analysis